Abstract
Oxidative stress underlies both obstructive sleep apnea (OSA) and atherosclerosis. The aim of the study was to assess the markers of oxidative stress in plasma at different stages of OSA in non-smoking obese Caucasian males aged 41–60, with normal oral glucose tolerance test. All patients were subjected to clinical and polysomnographic examinations. The stage of OSA severity was set according to the following criteria of the apnea-hypopnea index (AHI): AHI < 5/h – no disease (OSA-0; n = 26), AHI 5–15/h – mild disease (OSA-1; n = 26), AHI 16–30/h – moderate disease (OSA-2: n = 27), and AHI > 30/h obstructive episodes per hour – severe disease (OSA-3; n = 27). Plasma total antioxidant status (TAS) and thiobarbituric acid-reacting substances (TBARS), reflecting the level of lipid peroxides, were determined spectrophotometrically. We found that TAS decreased and TBARS increased significantly from OSA-0 to OSA-3. We conclude that the oxidative stress markers are conducive to setting the severity of OSA in normoglycemic patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Barceló A, Barbe F, de la Pena M, Vila M, Perez G, Pierola J, Duran J, Augusti AG (2000) Abnormal lipid peroxidation in patients with sleep apnoea. Eur Respir J 16:644–647
Barceló A, Barbe F, de la Pena M, Vila M, Perez G, Pierola J, Duran J, Augusti AG (2006) Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment. Eur Respir J 27:756–760
Baysal E, Taysi S, Aksoy N, Uyar M, Celenk F, Karatas ZA, Tarakcioglu M, Bilinç H, Mumbuç S, Kanlikama M (2012) Serum paraoxonase, arylesterase activity and oxidative status in patients with obstructive sleep apnea syndrome (OSAS). Eur Rev Med Pharmacol Sci 16:770–774
Bonsignore MR, Zito A (2008) Metabolic effects of the obstructive sleep apnea syndrome and cardiovascular risk. Arch Physiol Biochem 114:255–260
Celec P, Hodosy J, Behuliak M, Pálffy R, Gardlík R, Halčák L, Mucska I (2012) Oxidative and carbonyl stress in patients with obstructive sleep apnea treated with continuous positive airway pressure. Sleep Breath 16:393–398
Cofta S, Wysocka E, Piorunek T, Rzymkowska M, Batura–Gabryel H, Torliński L (2008) Oxidative stress markers in the blood of persons with different stages of obstructive sleep apnea syndrome. J Physiol Pharmacol 59(Suppl6):183–190
Dyugovskaya L, Lavie P, Lavie L (2002) Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165:934–939
Erel O (2004) A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 37:277–285
Framnes SV, Arble DM (2018) The bidirectional relationship between obstructive sleep apnoea and metabolic disease. Front Endocrinol (Lausanne) 9:440
Griendling KK, FitzGerald GA (2003) Oxidative stress and cardiovascular injury: part II: animal and human studies. Circulation 108:2034–2040
He J, Kryger M, Zorick F, Conway W, Roth T (1988) Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest 94:9–14
Hopps E, Canino B, Calandrino V, Montana M, Lo Presti R, Caimi G (2014) Lipid peroxidation and protein oxidation are related to the severity of OSAS. Eur Rev Med Pharmacol Sci 18:3373–3778
Kapur V, Auckley D, Chowdhuri S, Kuhlmann D, Mehra R, Ramar K, Harrod C (2017) Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med 13(3):479–504
Lavie L (2009) Oxidative stress – a unifying paradigm in obstructive sleep apnea and comorbidities. Prog Cardiovasc Dis 51:303–312
Lavie L, Lavie P (2009) Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link. Eur Respir J 33:1467–1484
Lavie P, Herer P, Peled R, Berger L, Yoffe N, Zomer J, Ami–Hai E (1995) Sleep apnea research mortality in sleep apnea patients: a multivariate analysis of risk factors. Sleep 18:149–157
Marin JM, Carrizo SJ, Vicente E, Agusti AG (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365:1046–1053
McNicholas WT, Bonsignore MR; Management Committee of EU Cost Action B26 (2007) Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 29:156–178
Ntalapascha M, Makris D, Kyparos A, Tsilioni I, Kostikas K, Gourgoulianis K, Kouretas D, Zakynthinos E (2012) Oxidative stress in patients with obstructive sleep apnea syndrome. Sleep Breath 19:549–555
Passali D, Corallo G, Yaremchuk S, Longini M, Proietti F, Passali GC, Bellussi L (2015) Oxidative stress in patients with obstructive sleep apnoea syndrome, vol 35, pp 420–425
Robinson GV, Peprell JC, Segal HC, Davies RJ, Strandling JR (2004) Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomized controlled trials. Thorax 59:777–782
Sales LV, Bruin VM, D’Almeida V, Pompéia S, Bueno OF, Tufik S, Bittencourt L (2013) Cognition and biomarkers of oxidative stress in obstructive sleep apnea. Clinics (Sao Paulo) 68:449–455
Somers V, White D, Amin R, Abraham W, Costa F, Culebras A, Daniels S, Floras J, Hunt C, Olson L, Pickering T, Russel R, Woo M, Young T (2008) Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol 52:686–717
Svatikova A, Wolk R, Lerman LO, Juncos LA, Greene EL, McConnell JP, Somers VK (2005) Oxidative stress in obstructive sleep apnoea. Eur Heart J 26:2435–2439
Youseff HA, Elsahzly MI, Rashed LA, Sabry IM, Ibrahim EK (2014) Thiobarbituric acid reactive substances (TBARS) a marker of oxidass in obstructive sleep apnea. Egypt J Chest Dis Tuberc 63:119–124
Conflict of Interest
The authors declare no conflicts of interests in relation to this article.
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the Ethics Committee of Poznań University of Medical Sciences in Poland.
Informed Consent
Written informed consent was obtained from all individual participants included in the study.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Cofta, S. et al. (2019). Oxidative Stress Markers and Severity of Obstructive Sleep Apnea. In: Pokorski, M. (eds) Pulmonology. Advances in Experimental Medicine and Biology(), vol 1222. Springer, Cham. https://doi.org/10.1007/5584_2019_433
Download citation
DOI: https://doi.org/10.1007/5584_2019_433
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-34650-8
Online ISBN: 978-3-030-34651-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)